151 related articles for article (PubMed ID: 22235799)
1. COX-2 and c-kit expression in canine gliomas.
Jankovsky JM; Newkirk KM; Ilha MR; Newman SJ
Vet Comp Oncol; 2013 Mar; 11(1):63-9. PubMed ID: 22235799
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 (COX-2) expression in canine intracranial meningiomas.
Rossmeisl JH; Robertson JL; Zimmerman KL; Higgins MA; Geiger DA
Vet Comp Oncol; 2009 Sep; 7(3):173-80. PubMed ID: 19691646
[TBL] [Abstract][Full Text] [Related]
3. Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.
Puputti M; Tynninen O; Sihto H; Blom T; Mäenpää H; Isola J; Paetau A; Joensuu H; Nupponen NN
Mol Cancer Res; 2006 Dec; 4(12):927-34. PubMed ID: 17189383
[TBL] [Abstract][Full Text] [Related]
4. KIT gene exon 11 mutations in canine malignant melanoma.
Chu PY; Pan SL; Liu CH; Lee J; Yeh LS; Liao AT
Vet J; 2013 May; 196(2):226-30. PubMed ID: 23069279
[TBL] [Abstract][Full Text] [Related]
5. Epidermal Growth Factor Receptor and Ki-67 Expression in Canine Gliomas.
Fraser AR; Bacci B; le Chevoir MA; Long SN
Vet Pathol; 2016 Nov; 53(6):1131-1137. PubMed ID: 27154542
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of tyrosine-kinase receptor c-kit mutations, mRNA and protein expression in canine lymphoma: might c-kit represent a therapeutic target?
Giantin M; Aresu L; Aricò A; Gelain ME; Riondato F; Comazzi S; Dacasto M
Vet Immunol Immunopathol; 2013 Aug; 154(3-4):153-9. PubMed ID: 23791075
[TBL] [Abstract][Full Text] [Related]
7. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
8. Presence of neural progenitors in spontaneous canine gliomas: A histopathological and immunohistochemical study of 20 cases.
Fernández F; Deviers A; Dally C; Mogicato G; Delverdier M; Cauzinille L; Gnirs K; Añor S; de la Fuente C; Fondevila D; Pumarola M
Vet J; 2016 Mar; 209():125-32. PubMed ID: 26831167
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical evaluation of tissue factor, fibrin/fibrinogen and D-dimers in canine gliomas.
de la Fuente C; Pumarola M; Blasco E; Fernández F; Viu J; Añor S
Vet J; 2014 Jun; 200(3):387-92. PubMed ID: 24745770
[TBL] [Abstract][Full Text] [Related]
10. Canine subcutaneous mast cell tumors: cellular proliferation and KIT expression as prognostic indices.
Thompson JJ; Yager JA; Best SJ; Pearl DL; Coomber BL; Torres RN; Kiupel M; Foster RA
Vet Pathol; 2011 Jan; 48(1):169-81. PubMed ID: 21160022
[TBL] [Abstract][Full Text] [Related]
11. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study.
Takeuchi Y; Fujino Y; Watanabe M; Takahashi M; Nakagawa T; Takeuchi A; Bonkobara M; Kobayashi T; Ohno K; Uchida K; Asano K; Nishimura R; Nakayama H; Sugano S; Ohashi Y; Tsujimoto H
Vet J; 2013 Jun; 196(3):492-8. PubMed ID: 23384436
[TBL] [Abstract][Full Text] [Related]
12. Molecular signalling pathways in canine gliomas.
Boudreau CE; York D; Higgins RJ; LeCouteur RA; Dickinson PJ
Vet Comp Oncol; 2017 Mar; 15(1):133-150. PubMed ID: 25808605
[TBL] [Abstract][Full Text] [Related]
13. A subset of human gliomas shows over-expression of KIT without its amplification.
Saini M; Jha AN; Abrari A; Ali S
Gene; 2012 Apr; 497(2):155-63. PubMed ID: 22330882
[TBL] [Abstract][Full Text] [Related]
14. Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas.
Murakami A; Mori T; Sakai H; Murakami M; Yanai T; Hoshino Y; Maruo K
Vet Comp Oncol; 2011 Sep; 9(3):219-24. PubMed ID: 21848624
[TBL] [Abstract][Full Text] [Related]
15. Molecular alterations of KIT oncogene in gliomas.
Gomes AL; Reis-Filho JS; Lopes JM; Martinho O; Lambros MB; Martins A; Schmitt F; Pardal F; Reis RM
Cell Oncol; 2007; 29(5):399-408. PubMed ID: 17726262
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
Shono T; Tofilon PJ; Bruner JM; Owolabi O; Lang FF
Cancer Res; 2001 Jun; 61(11):4375-81. PubMed ID: 11389063
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance.
Hara A; Okayasu I
Acta Neuropathol; 2004 Jul; 108(1):43-8. PubMed ID: 15088099
[TBL] [Abstract][Full Text] [Related]
18. EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas.
Xu K; Shu HK
Cancer Res; 2007 Jul; 67(13):6121-9. PubMed ID: 17616668
[TBL] [Abstract][Full Text] [Related]
19. Two canine Merkel cell tumours: immunoexpression of c-KIT, E-cadherin, beta-catenin and S100 protein.
Gil da Costa RM; Rema A; Pires MA; Gärtner F
Vet Dermatol; 2010 Apr; 21(2):198-201. PubMed ID: 19706008
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping.
Higgins RJ; Dickinson PJ; LeCouteur RA; Bollen AW; Wang H; Wang H; Corely LJ; Moore LM; Zang W; Fuller GN
J Neurooncol; 2010 May; 98(1):49-55. PubMed ID: 19967449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
